NANOBIOTIX
NANO.PADrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NBTXR3 | Phase 2 | Locally-Advanced Non-Small Cell Lung Cancer | - | - |
Frequently asked questions
What is in NANOBIOTIX's drug pipeline?→
CatalystAlert tracks 1 drug candidate in NANOBIOTIX's (NANO.PA) pipeline across Phase 2. Its lead program is NBTXR3 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NANOBIOTIX's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NANOBIOTIX (NANO.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NANO.PA biotech catalysts?→
Add NANO.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NANOBIOTIX's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.